Sudden Cardiac Arres - China

Sudden cardiac arrest (SCA) occurs unexpectedly and can be fatal if not treated immediately.

The window for survival is extremely narrow, and for every minute without defibrillation, the chances of survival drop by 10%.

This stark reality has made automated external defibrillators (AEDs) indispensable in emergency medical response.

AEDs provide a life-saving shock to the heart, which can restore its normal rhythm in cases of sudden cardiac arrest.

What Is an Automated External Defibrillator (AED)

An automated external defibrillator (AED) is a compact, portable device that plays a crucial role in the immediate treatment of sudden cardiac arrest (SCA).

It works by diagnosing abnormal heart rhythms and delivering an electrical shock to restore normal heart function.

AEDs are primarily used in emergency situations and can be operated by bystanders with little to no medical knowledge, making them essential in places where medical personnel may not be immediately available.

Company Contact:

• Posted By: Jousing Medical Co., Ltd.

• Phone: +86 21 64311308

• Address: 301, 401, Building 21, No. 200, Xingpu Road, Suzhou Industrial Park, Suzhou , Jiangsu , China

• Email:

• Website: https://www.jousingaed.com/

• Business Description: Jousing Medical is China's first domestic enterprise to obtain an AED registration certificate, providing AED products and pre-hospital emergency solutions.
  
  The company participated in drafting the NMPA's "Technical Guiding Principles for Defibrillator Product Registration", and has been recognized as a National High-Tech Enterprise and a National-Level "Specialized, Refined, Unique, and New" (Little Giant) Enterprise.
  
  In 2022, Jousing Medical provided exclusive AED support for the Beijing Winter Olympics.
  
  Jousing AED deployments have reached nearly 100,000 units, securing the second-highest domestic market share, and its products have entered over 30 countries and regions.
  
  Jousing AEDs demonstrated a first-shock success rate exceeding 98% in animal trials and have successfully resuscitated over 150 patients to date.